Financhill
Back

Entero Therapeutics Stock Predictions

Entero Therapeutics Stock Forecast

  • Is Entero Therapeutics Stock Undervalued?
    The current Entero Therapeutics [ENTO] share price is $0.49. The Score for ENTO is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • ENTO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Entero Therapeutics Stock Go Up Next Year?

Data Unavailable

Entero Therapeutics Stock Rating

Data Unavailable

Entero Therapeutics Stock Price History

Is ENTO stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ENTO is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
enterothera.com

52-Week Data

52-Week High:
1.15
52-Week Low:
0.19

Prediction Charts

Market Cap:
2.3M
Price in USD:
0.49
Volume:
284.5K
Beta:
1.28

Technical Analysis

SMA50:
0.44
SMA100:
0.46
SMA200:
0.50
52-Wk Change:
-56.15%

Stock Predictions

  • Is Entero Therapeutics stock public?
    Yes, Entero Therapeutics is a publicly traded company.
  • What is the Entero Therapeutics stock quote today?
    The Entero Therapeutics stock price is 0.49 USD today.
  • How to buy Entero Therapeutics stock online?
    You can buy Entero Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-23 0.51 0.50 0.52 0.48
Jun-24 0.49 0.48 0.52 0.46
Jun-25 0.45 0.46 0.48 0.45
Jun-26 0.47 0.44 0.52 0.43
Jun-27 0.43 0.38 0.45 0.36
Jun-30 0.37 0.40 0.40 0.36
Jul-1 0.40 0.39 0.41 0.39
Jul-2 0.39 0.41 0.41 0.39
Jul-3 0.41 0.40 0.41 0.40
Jul-7 0.40 0.40 0.41 0.39
Jul-8 0.39 0.53 0.57 0.39
Jul-9 0.56 0.55 0.57 0.44
Jul-10 0.46 0.49 0.49 0.45
Jul-11 0.47 0.49 0.49 0.46

Entero Therapeutics Earnings

Data Unavailable

Entero Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.39 per share, and a decrease next year of $0.22 per share.

* Entero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.